Skip to main content

Month: May 2021

Seanergy Maritime Holdings Corp. Reports Financial Results for the First Quarter Ended March 31, 2021

Highlights of the First Quarter of 2021:Net revenues: $20.4 million in Q1 2021, as compared to $13.3 million in Q1 2020, up 53% Net loss: $1.3 million in Q1 2021, as compared to net loss of $8.3 million in Q1 2020 EBITDA1: $6.5 million in Q1 2021, as compared to $1.0 million in Q1 2020, up 567% Adjusted EBITDA1: $7.9 million in Q1 2021, as compared to $1.4 million in Q1 2020, up 483% Cash position2: $58.1 million in Q1 2021, as compared to $23.7 million in Q4 2020, up 145% Debt and other financial liabilities3: $131.5 million in Q1 2021, as compared to $169.8 million in Q4 2020 Shareholders’ equity: $188.1 million in Q1 2021, as compared to $ 95.7 million in Q4 2020, up 97%First Quarter & Recent developments:Acquisition of 5 modern Japanese Capesize vessels, for a total investment of $134.3 million and a fleet increase to 16...

Continue reading

Information on the First Quarter Dividend Announced by the Company

ATHENS, Greece, May 25, 2021 (GLOBE NEWSWIRE) — Star Bulk Carriers Corp. (the “Company” or “Star Bulk”) (Nasdaq: SBLK),  will distribute a $0.30 cash dividend payable on or about June 14th, 2021 to shareholders of the Common Shares of record on May 31st, 2021. An ex-dividend date of May 27th, 2021 has been established. About Star Bulk Star Bulk is a global shipping company providing worldwide seaborne transportation solutions in the dry bulk sector. Star Bulk’s vessels transport major bulks, which include iron ore, minerals and grain, and minor bulks, which include bauxite, fertilizers and steel products. Star Bulk was incorporated in the Marshall Islands on December 13, 2006 and maintains executive offices in Athens, Oslo, New York, Limassol and Singapore. Its common stock trades on the Nasdaq Global Select...

Continue reading

Sift to Acquire Chargeback, Providing Merchants With Complete Protection Against Payment Fraud

Combined companies offer unified solution to defend against both true and friendly fraud SAN FRANCISCO and SALT LAKE CITY, May 25, 2021 (GLOBE NEWSWIRE) — Sift, the leader in Digital Trust & Safety, today announced that it has signed a definitive agreement to acquire Chargeback, the pioneer in real-time dispute management for merchants. The two companies are coming together as both e-commerce growth and payment fraud are accelerating, and as the Fraud Economy—the sophisticated and interconnected network of cybercriminals and their methods—has rapidly expanded. With the addition of Chargeback to Sift’s platform, merchants will gain access to a complete solution that addresses risk before, during, and after user transactions. Specifically, the two companies prevent both “true” fraud, which occurs when stolen credentials or payment...

Continue reading

Cryptologic Corp. Announces Entrance Into an Amended and Restated Share Purchase Agreement for the Proposed Acquisition of the Storø Gold Project and Receipt of Conditional Approval for the Acquisition From the Canadian Securities Exchange

TORONTO, May 25, 2021 (GLOBE NEWSWIRE) — Cryptologic Corp. (CSE:CRY) (the “Company” or “Cryptologic”) is pleased to announce that it has entered into an amended and restated share purchase agreement (the “Amended and Restated SPA”) dated May 21, 2021 with Greenland Resources Inc. (the “Seller”), RSG Mining Corp. (“RSG Mining”) and certain other parties to acquire 100% of the outstanding shares of the Seller’s wholly-owned subsidiary, Copenhagen Minerals Inc. (“Copenhagen”), which owns 100% of a mineral exploration license known as the Storø Gold Project, located in Greenland (the “Acquisition”). The Amended and Restated SPA amends and restates the share purchase agreement (the “SPA”) entered into on January 27, 2021, as announced on January 28, 2021. The Company is also pleased to announce that it has received conditional approval...

Continue reading

Trinity Biotech Announces Results for Q1, 2021

DUBLIN, Ireland, May 25, 2021 (GLOBE NEWSWIRE) — Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, today announced results for the quarter ended March 31, 2021. Quarter 1 Results Total revenues for Q1, 2021 were $25.6m which compares to $21.2m in Q1, 2020, an increase of 20.9% and which were broken down as follows:  2020Quarter 1 2021Quarter 1 Increase/(decrease)  US$’000 US$’000 %Point-of-Care 3,335 1,888 (43.4%)Clinical Laboratory 17,842 23,706 32.9%Total 21,177 25,594 20.9%Point-of-Care revenues for Q1, 2021 decreased from $3.3m to $1.9m when compared to Q1, 2020, a decrease of 43.4%. This was primarily due to a delay in the issue of HIV rapid test orders from Africa as a result of COVID-19. We are seeing evidence...

Continue reading

First Trust Portfolios Canada Announces Cap, Buffer and Dates of May Buffer ETF

TORONTO, May 25, 2021 (GLOBE NEWSWIRE) — FT Portfolios Canada Co. (“First Trust Canada”), announced today that the cap, buffer and dates for the next Target Outcome Period for the First Trust Cboe Vest U.S. Equity Buffer ETF – May (TSX: MAYB.F) (the “fund” or “May Buffer ETF”) are as follows:TICKER CAP BUFFER OUTCOME PERIODMAYB.F 12.50% (Gross) 10% 24/05/2021 – 20/05/2022The initial Target Outcome Period for MAYB.F concluded on May 21, 2021 and the upside cap for the new Target Outcome Period has been reset to prevailing market conditions. The fund seeks an outcome that provides investors with returns (before fees, expenses and taxes) that match the price return of the SPDR® S&P 500® ETF Trust (“SPY” or “underlying ETF”), up to a predetermined upside cap, while providing a buffer against potential SPY losses. The...

Continue reading

WisdomTree Announces +Crypto Model Portfolios for Advisors in Collaboration with Onramp Invest which features Gemini Integration

NEW YORK, May 25, 2021 (GLOBE NEWSWIRE) — WisdomTree Investments, Inc. (NASDAQ: WETF), an exchange-traded fund (“ETF”) and exchange-traded product (“ETP”) sponsor and asset manager, announced today the WisdomTree +Crypto Model Portfolios. The WisdomTree +Crypto Model Portfolios are expected to be available for advisors to view as an educational resource, including via Onramp Invest, a financial technology start-up focused on integrating crypto assets into advisor workflows, with integration into Gemini, a leading crypto platform. Will Peck, WisdomTree’s Head of Strategy and Emerging Technologies, said, “WisdomTree has always sought to be a leader in providing educational information and tools for advisors. Advisors are fielding questions about crypto assets now more than ever. Our new +Crypto Model Portfolios are intended to serve...

Continue reading

REMINDER/Dorel Industries Inc. Announces Annual Meeting of Shareholders

Wednesday, May 26, 2021 at 10:00 A.M. In light of the COVID-19 pandemic, shareholders are asked to participate by live audio webcast at https://www.dorel.com/pages/shareholder-information  Shareholders will have the ability to interact with Dorel Industries Inc. Senior Management by submitting questions to ir@dorel.com. To be sure your questions are addressed during the Q&A portion of the annual meeting, it is recommended that you submit them no later than 5 p.m. on May 24, 2021. MONTREAL, May 25, 2021 (GLOBE NEWSWIRE) — Dorel Industries Inc. (TSX: DII.B, DII.A) is a global organization, operating three distinct businesses in juvenile products, bicycles and home products. Dorel’s strength lies in the diversity, innovation and quality of its products as well as the superiority of its brands. Dorel Juvenile’s powerfully...

Continue reading

Supernus to Present at Jefferies Virtual Healthcare Conference

ROCKVILLE, Md., May 25, 2021 (GLOBE NEWSWIRE) — Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, today announced that Jack Khattar, President and CEO of Supernus Pharmaceuticals, will present a company overview at the Jefferies Virtual Healthcare Conference on Tuesday, June 1, 2021, at 1:30 p.m. ET. A live webcast of the presentation can be accessed by visiting Events & Presentations in the Investor Relations section on the Company’s website at www.supernus.com. An archived replay will be available for 60 days on the Company’s website following the conference. About Supernus Pharmaceuticals, Inc. Supernus Pharmaceuticals is a biopharmaceutical company focused on developing and...

Continue reading

Acer Therapeutics Plans NDA Submission for ACER-001 in Q3 2021 Following Pre-NDA Meeting with FDA

NEWTON, Mass. and GENEVA, Switzerland, May 25, 2021 (GLOBE NEWSWIRE) — Acer Therapeutics Inc. (Nasdaq: ACER)(“Acer”), a pharmaceutical company focused on the acquisition, development and commercialization of therapies for serious rare and life-threatening diseases with significant unmet medical needs, and RELIEF THERAPEUTICS Holding AG (SIX: RLF, OTCQB: RLFTF)(“Relief”), a biopharmaceutical company with its lead compound RLF-100TM (aviptadil) in advanced clinical development to treat severe COVID-19 patients, today announced the outcome of Acer’s pre-New Drug Application (NDA) meeting with the U.S. Food and Drug Administration (FDA) for ACER-001 for the treatment of Urea Cycle Disorders (UCDs). ACER-001 is a proprietary immediate release multi-particulate powder formulation of sodium phenylbutyrate (NaPB) with a taste-masked coating....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.